Help Still Available for Actos Bladder Cancer Victims
In April 2015, Takeda Pharmaceuticals agreed to a $2.4 billion settlement to resolve thousands of lawsuits claiming the diabetes drug, Actos caused their bladder cancer. This is believed to be the largest settlement ever for a drug still on the market. Help is still available even if you didn’t make it into the first settlement.
Read MoreActos Manufacturer Agrees to Landmark $2.37 Billion Settlement
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In a huge win for justice and consumer rights, Takeda Pharmaceutical has agreed to pay $2.4 billion to settle thousands of lawsuits from patients and their family members who said that the company’s diabetes drug Actos caused bladder cancer. Takeda, a
Read MoreActos Bladder Cancer Verdict in Favor of Plaintiff in Philadelphia
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Things are heating up in Actos litigation, with defendant Takeda hit with another verdict rising from the use of the drug the development of bladder cancer. On February 12th, Takeda Pharmaceuticals Inc. was hit with a $2.3 million verdict after a
Read MoreJury Finds Actos Manufacturer Intentionally Destroyed Evidence
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. This is truly deplorable conduct on behalf off the manufacturer of Actos. Takeda Pharmaceutical Co. was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked
Read More